HB 379: "An Act relating to controlled substances."
00 HOUSE BILL NO. 379 01 "An Act relating to controlled substances." 02 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA: 03 * Section 1. AS 11.71.140 is amended by adding a new subsection to read: 04 (e) Schedule IA includes, unless specifically excepted or unless listed in 05 another schedule, any material, compound, mixture, or preparation which contains any 06 quantity of the following substances, or which contains any of its salts, isomers, 07 whether optical, position, or geometric, or salts of isomers whenever the existence of 08 those salts, isomers, or salts of isomers is possible within the specific chemical 09 designation: 10 (1) gamma-hydroxybutyric acid (GHB) (some other names include 11 gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium 12 oxybate; sodium oxybutyrate); 13 (2) gamma butyrolactone (GBL); 14 (3) 1,4-butanediol. 15 * Sec. 2. AS 11.71 is amended by adding a new section to read:
01 Sec. 11.71.193. Analog controlled substances. (a) In this chapter, references 02 to controlled substances include all controlled substance analogs of that controlled 03 substance. 04 (b) In this section, "controlled substance analog" means a substance 05 (1) the chemical structure of which is substantially similar to the 06 chemical structure of a substance classified in AS 11.71.140 or 11.71.150; or 07 (2) that has or is intended to have a stimulant, depressant, or 08 hallucinogenic effect on the central nervous system that is substantially similar to, or 09 greater than, the effect of a controlled substance classified in AS 11.71.140 or 10 11.71.150. 11 (c) This section does not apply to 12 (1) any substance for which there is an approved new drug application 13 as defined under 21 U.S.C. 355 (sec. 505 of the Federal Food, Drug, and Cosmetic 14 Act) or that is generally recognized as safe and effective for use under 21 U.S.C. 351 - 15 353 (secs. 501, 502, and 503 of the Federal Food, Drug, and Cosmetic Act) and 21 16 C.F.R. 330 et seq.; 17 (2) with respect to a particular person, any substance for which an 18 exemption is in effect for investigational use for that person under 21 U.S.C. 355 (sec. 19 505 of the Federal Food, Drug, and Cosmetic Act) if the conduct with respect to that 20 substance is allowed by the exemption; or 21 (3) any substance, before an exemption as specified in (2) of this 22 subsection takes effect with respect to the substance, to the extent the substance is not 23 intended for human consumption. 24 * Sec. 3. AS 11.71.170(b)(28) is repealed.